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Abstract
Background—Despite its high prevalence, essential tremor (ET) is among the most poorly 
understood neurological diseases. The presence and extent of Purkinje cell (PC) loss in ET is the 
subject of controversy. PCs are a major storehouse of central nervous system gamma-aminobutyric 
acid (GABA), releasing GABA at the level of the dentate nucleus. It is therefore conceivable that 
cerebellar dentate GABA concentration could be an in vivo marker of PC number.
Objectives—We used in-vivo 1H magnetic resonance spectroscopy (MRS) to quantify GABA 
concentrations in two cerebellar volumes of interest, left and right, which included the dentate 
nucleus, comparing 45 ET cases to 35 age-matched controls.
Methods—1H MRS was performed using a 3.0 Tesla Siemens Tim Trio scanner. The MEGA-
PRESS J-editing sequence was used for GABA detection in two cerebellar volumes of interest 
(left and right) that included the dentate nucleus.
Results—The two groups did not differ with respect to our primary outcome of GABA 
concentration (given in institutional units). For right dentate: [GABA] in ET cases = 2.01 ± 0.45 
and [GABA] in controls = 1.86 ± 0.53, p = 0.17. For left dentate: [GABA] in ET cases = 1.68 
± 0.49 and [GABA] controls = 1.80 ± 0.53, p = 0.33. The controls had similar dentate [GABA] in 
the right vs. left dentate (p = 0.52); however, in ET cases, the value on the right was considerably 
higher than on the left (p = 0.001).
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Conclusions—We did not detect a reduction in dentate GABA concentration in ET cases vs. 
controls. One interpretation of the finding is that it does not support the existence of PC loss in ET; 
however, an alternative interpretation is the observed pattern could be due to the effects of terminal 
sprouting in ET (i.e., collateral sprouting from surviving PCs making up for the loss of GABA-
ergic terminals from PC degeneration). Further research is needed.
Keywords
Essential tremor; magnetic resonance spectroscopy; gamma-aminobutyric acid; dentate nucleus; 
Purkinje cell; cerebellum; neurodegeneration
Introduction
Despite its extraordinarily high prevalence (1–3), essential tremor (ET) is among the most 
poorly understood neurological diseases (4, 5). On the most basic biological level, little is 
known about its underlying pathophysiology and pathological anatomy (4, 5). Recent 
postmortem studies report a 30 – 40% loss of Purkinje cells (PCs) in ET (6–8), suggesting 
that on a mechanistic level, this common neurological disease could be neurodegenerative 
(9–11). However, the presence and extent of such PC loss in ET is the subject of controversy 
(12–14), and therefore, remains a focus of current scrutiny.
PCs are a major storehouse of the central nervous system inhibitory neurotransmitter 
gamma-aminobutyric acid (GABA), releasing GABA into the post-synaptic cleft at the level 
of the cerebellar dentate nucleus (15, 16). Thus, it is conceivable that cerebellar dentate 
GABA level could be an in vivo marker of PC number (17). In this cross-sectional study, we 
used in-vivo magnetic resonance spectroscopy (MRS) to quantify GABA concentrations in 
two cerebellar volumes of interest, left and right, which included the dentate nucleus, 
comparing ET cases to age-matched controls. The research, by testing the hypothesis that 
these concentrations will be low in ET patients compared to age-matched controls, could 
elucidate a critically important question about the underlying pathophysiology of ET. Aside 
from its scientific value, demonstrating low MRS-assessed GABA concentrations in ET 
could also have an important clinical implication, that is, such concentrations could serve as 
an imaging biomarker for ET. No imaging biomarkers for ET currently exist.
Materials and Methods
Subjects and clinical evaluation
ET cases were recruited from several sources (2013 – 2016), including a clinical-
epidemiological study of ET (18), one of the author’s (E.D.L.) neurological practices, and 
study advertisements (17). Inclusion criteria were: (1) a prior diagnosis of ET assigned by a 
treating neurologist, (2) willingness to undergo a magnetic resonance imaging (MRI) scan, 
and (3) living within two hours of the recruiting site. Exclusion criteria were: (1) heavy 
exposure to ethanol (as previously defined)(19), (2) history of a neurodegenerative disease 
(Parkinson’s disease, Alzheimer’s disease), (3) prior deep brain stimulation or other 
neurosurgery (e.g., gamma knife, thalamotomy, focused ultrasound) for ET, or (4) a reason 
to be excluded from MRI scanning (e.g., metal in their bodies). Furthermore, we excluded 
Louis et al. Page 2
Cerebellum. Author manuscript; available in PMC 2019 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
cases who were taking medications that bind to the GABAA receptor or that enhance GABA 
tone (e.g., clonazepam, diazepam, lorazepam, gabapentin, phenobarbital, progabide, 
propofol, tigabine, valproate, vigabatrin); however, a small number of cases (n = 9) who 
were taking primidone were enrolled specifically for the purposes of a sub-study that 
proposed to analyze the effects of primidone on MRS results (17). In total, 460 ET cases 
were excluded for one of the aforementioned reasons.
Normal control subjects were recruited during the same time period and from the same 
sources as the ET cases with some being spouses of the ET cases. They were matched to ET 
cases based on age. As cases were more readily available, their recruitment occurred more 
easily than that of controls, and this contributed to an unequal number of cases and controls. 
Exclusion criteria included a history of ET or a family history of ET (i.e., a reportedly 
affected first-degree or second-degree relative) or presence on two hand-drawn screening 
Archimedes spirals of a tremor rating > 1 (rated by a senior neurologist specializing in 
movement disorders (E.D.L.) who used the Washington Heights-Inwood Genetic Study of 
ET (WHIGET) tremor rating scale, as described below) (17, 20).
Upon enrollment, a trained research assistant conducted an in-person evaluation of all ET 
cases and controls, administering demographic and medical history questionnaires, which 
included collection of data on medications and daily use of ethanol, which was coded 
ordinally (Table 1) (17). The Montreal Cognitive Assessment (MoCA) was administered to 
briefly assess global cognitive function (21). During this assessment, a videotaped 
neurological examination was also performed on all ET cases and controls, which included 
one test for postural tremor and five for kinetic tremor (including pouring, drinking, using a 
spoon, finger-nose-finger maneuver, and drawing an Archimedes spiral, 12 tests total). A 
senior neurologist specializing in movement disorders (E.D.L.) used a reliable and valid 
clinical rating scale, the WHIGET tremor rating scale, to rate postural and kinetic tremor 
during each test: 0 (none), 1 (mild), 2 (moderate), 3 (severe), resulting in a total tremor score 
(range = 0 – 36) (17, 20). Diagnoses of ET were re-confirmed by E.D.L. using the 
videotaped neurological examination and WHIGET diagnostic criteria (moderate or greater 
amplitude kinetic tremor [tremor rating ≥ 2] during at least three tests or a head tremor, in 
the absence of Parkinson’s disease, dystonia or another cause) (22).
The study protocol was approved by the Human Subjects Institutional Review Board at Yale 
University, Purdue University and Weill Cornell Medical College. Written informed consent 
was obtained from each subject upon enrollment in the study.
In vivo MRI/MRS measurements
MRI and 1H MRS exams were performed on a 3.0 Tesla Siemens Tim Trio scanner 
(Siemens Healthcare, Erlangen, Germany), equipped with a 32-channel head coil (17). All 
scans were performed at Weill Cornell Medical College. Fast T2-weighted images were 
acquired in all three orientations to ensure exact localization of the MRS volumes of interest 
(VOIs) (17). GABA-edited MRS data was acquired from two VOIs containing the left and 
right cerebellar dentate nucleus, respectively (both 25 mm × 25 mm × 25 mm, 128 averages) 
(Figure 1). Both dentate nuclei were clearly identified on the T2-weighted images on both 
axial and coronal planes. Each GABA VOI was placed on the axial plane such that the entire 
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dentate nucleus was included, given the fact that this is the level at which the Purkinje cells 
release their GABA into the synaptic cleft (15), while minimizing contributions from 
vascular and CSF compartments. The VOI was then confirmed to be completely within the 
cerebellum on the coronal plane. The MEGA-PRESS J-editing sequence was used for 
GABA detection (TR/TE = 1500/68 ms) (23).
196 averages were acquired with the spectrally selective editing pulse centered at 1.9 ppm 
(edit-on) and 196 averages with the pulse centered at 7.5 ppm (edit-off) in an interleaved 
fashion (17). The resulting difference spectrum contains a GABA peak at 3.0 ppm, which 
also includes contributions from co-edited macromolecules and homocarnosine, a dipeptide 
consisting of GABA and histidine (17). Therefore, the signal will be referred to as GABA+. 
For both VOIs, a reference spectrum was acquired without water suppression. These 
reference spectra were then used for phase and frequency correction of the corresponding 
water-suppressed spectra. FASTESTMAP shimming (IPR#577; Siemens Healthcare) was 
performed before each voxel measurement to achieve water line widths of < 20 Hz (24). In 
order to determine voxel tissue composition, high-resolution MPRAGE images were 
acquired (TR/TE/TI = 2300/2.91/900 ms, flip angle = 9°, bandwidth: 240 Hz/pixel, voxel 
size: 1.0 mm × 1.0 mm × 1.2 mm, GRAPPA = 2). Every effort was made to ensure the 
subjects were as comfortable as possible without moving in the scanner (17).
Data processing and analysis
MRS data processing and quantification were performed with LCModel 6.3–0L (25), fitting 
each spectrum as a weighted linear combination of basis spectra from individual metabolites 
(17). For fitting the MEGA-PRESS spectra, basis sets were generated from density matrix 
simulations of the sequence using published values for chemical shifts and J-couplings from 
Kaiser et al. (26), with an exact treatment of metabolite evolution during the two frequency-
selective MEGA inversion pulses (17). LCModel fitting %SD values were lower than 20% 
for GABA+ in all spectra. GABA+ concentrations were derived from raw GABA+ output 
values from LCModel, multiplied with a water calibration factor provided by LCModel 
(FCALIB factor). Due to scaling uncertainties, GABA+ concentration values are given in 
institutional units, but are proportional to and in the range of the true GABA+ concentrations 
in mM (17).
The reproducibility of GABA-edited MRS in the cerebellum was determined by Long et al. 
(27) who showed that the intra-individual test-retest coefficient of variance (CV) in an 
elderly population only ranged between 4 and 13.8%. However, an elderly population shows 
a rather high inter-individual CV, ranging from 13 – 24 %, compared to younger populations 
with typical inter-individual CVs of 4 – 15% (28–30).
To determine and correct for the tissue composition of the MRS voxels, MPRAGE images 
were segmented into grey matter (GM), white matter (WM) and cerebrospinal fluid (CSF) 
using statistical parametric mapping (SPM12, Wellcome Department of Imaging 
Neuroscience, London, UK) (17). The MRS voxels were then registered to the tissue maps 
using an in-house MATLAB 2013a (MathWorks Inc., Natick, MA, USA) code to calculate 
the proportion of each type of tissue within each voxel. GABA levels corrected for CSF 
were obtained using the method described by Chowdhury et al (31).
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The volume of the left and right dentate nucleus, in c.c., was estimated from the high 
resolution 3D T1-Weighted MRI sequence using SPM12 and the SUIT toolbox (32). This 
refers to the Spatially Unbiased Infra-tentorial Template of the cerebellum and brainstem 
(33). The cerebellum was isolated and normalized or deformed into the SUIT atlas template. 
This procedure aligns individual fissures and reduces their spatial spread as well as improves 
on alignment of the deep cerebellar nuclei resulting in an estimate of 34 cerebellar lobules 
including the dentate.
Sample size calculation
Given the 30 – 40% loss of PCs in our postmortem studies of ET (6, 34), at the start of the 
study, we had hypothesized a similar reduction in cerebellar dentate GABA level in ET 
cases. Given an average (right and left) dentate GABA concentration = 1.83 ± 0.53 in 
controls, and assuming alpha = 0.05, our sample had 85.7% power to detect as little as a 
20% reduction in average GABA concentration in ET cases.
Statistical analyses
All analyses were performed in SPSS (version 24.0). We compared demographic and 
clinical features of ET cases and controls using Student’s t tests, chi-square tests, and 
Fisher’s exact tests (for normally distributed variables) and Mann Whitney tests (for 
variables that were not normally distributed) (Table 1). We also compared dentate GABA 
concentration by group (e.g., men vs. women, ET case vs. controls) using Student’s t tests 
and within subjects (right vs. left) using a paired sample t test. We performed a series of 
secondary analyses in which we (1) excluded ET cases taking primidone, (2) compared ET 
cases with head and jaw tremor to controls. We correlated dentate GABA concentration with 
total tremor score, tremor duration and daily use of ethanol (ordinally distributed), using 
either Pearson’s or Spearman’s r, depending on the distribution of the variables.
To see whether the arm with the most severe tremor corresponded to the side of the dentate 
with the lowest GABA concentration, two indices were created. The first was the tremor 
score on the right minus the tremor score on the left, which we called tremor asymmetry. 
The second was right dentate GABA concentration minus left dentate GABA concentration, 
which we called GABA asymmetry. We then correlated the two using a Pearson’s 
correlation coefficient.
Results
The ET cases and controls were similar in age, race and a variety of additional demographic 
factors (marital status, education, smoking) and clinical variables (handedness, MoCA score, 
number of prescription medications, ethanol use) (Table 1). They differed by gender; 
however, gender was not associated with dentate GABA concentration (for right dentate 
GABA concentration in men [1.95 ± 0.48] vs. women [1.95 ± 0.50], t = 0.01, p = 0.99, and 
for left dentate GABA concentration in men [1.69 ± 0.48] vs. women [1.77 ± 0.54], t = 0.61, 
p = 0.54). The age of ET onset was ≤ 60 in 39 (86.7%) of 45 ET cases and 64.4% had been 
prescribed medication at some point for their tremor. The median tremor duration was 30 
years. None of the cases or controls had been exposed to chemotherapy. None had been 
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heavy ethanol users and few of the cases or controls drank more than one drink per day 
(Table 1).
In our main analysis, we compared dentate GABA concentration in ET cases and controls. 
The two groups did not differ: for right dentate GABA concentration, ET cases = 2.01 ± 0.45 
and controls = 1.86 ± 0.53, p = 0.17; for left dentate GABA concentration, ET cases = 1.68 
± 0.49 and controls = 1.80 ± 0.53, p = 0.33. The respective volumes of the dentate for each 
group is also given in Table 1. When we compared dentate GABA concentration/dentate 
volume in cases vs. controls, there were no differences on the right (1.42 ± 0.45 vs. 1.29 
± 0.42, p = 0.18) or the left (1.28 ± 0.47 vs. 1.31 ± 0.47, p = 0.75).
In the majority of ET cases (34/45 = 75.6%) and the majority of controls (22/35 = 62.9%), 
the dentate GABA concentration was higher in the right than the left dentate. In ET cases as 
a whole, the mean GABA concentration was significantly higher in the right than left dentate 
nucleus (2.01 ± 0.45 vs. 1.68 ± 0.49, p = 0.001, Table 1, Figure 2A); by contrast, the mean 
dentate GABA concentration was similar on the right and left among controls (1.86 ± 0.53 
vs. 1.80 ± 0.53, p = 0.52, Table 1, Figure 2B). Restricting the sample to the 38 right handed 
cases and 31 right handed controls yielded similar results: in ET cases as a whole, the mean 
GABA concentration was significantly higher in the right than left dentate nucleus (1.98 
± 0.40 vs. 1.69 ± 0.51, p = 0.004); by contrast, the mean dentate GABA concentration was 
similar on the right and left among controls (1.84 ± 0.55 vs. 1.77 ± 0.55, p = 0.55). The 
mean value of GABA asymmetry (right dentate GABA concentration minus left dentate 
GABA concentration) was 0.34 ± 0.62 in ET cases and 0.07 ± 0.62 in controls (p = 0.05) 
(Figure 3).
Nine ET cases were taking primidone; in a prior analysis, we did not find a difference in 
dentate GABA concentrations between 6 ET patients taking daily primidone and 26 ET 
patients not taking primidone (17). Nonetheless, in a secondary analysis, we excluded these 
nine cases, comparing dentate GABA concentration in the remaining 36 ET cases and 35 
controls. The two groups did not differ: for right dentate GABA concentration, ET cases = 
2.01 ± 0.46 and controls = 1.86 ± 0.52, p = 0.21; for left dentate GABA concentration, ET 
cases = 1.69 ± 0.52 and controls = 1.80 ± 0.53, p = 0.39.
In another secondary analysis, we compared 25 ET cases with head or jaw tremor to the 35 
controls. In these analyses, ET cases with head or jaw tremor had higher dentate GABA 
concentration rather than lower dentate GABA concentration than controls on the right. 
Thus, for right dentate GABA concentration, ET cases with head or jaw tremor = 2.14 
± 0.38 and controls = 1.86 ± 0.53, p = 0.03; for left dentate GABA concentration, ET cases 
with head or jaw tremor = 1.70 ± 0.53 and controls = 1.80 ± 0.53, p = 0.48.
In ET cases, neither total tremor score nor tremor duration was correlated with dentate 
GABA concentration: total tremor score and right dentate GABA concentration Pearson’s r 
= −0.05, p = 0.73, total tremor score and left dentate GABA concentration Pearson’s r = 
−0.20, p = 0.20, tremor duration and right dentate GABA concentration Pearson’s r = −0.05, 
p = 0.73, and tremor duration and left dentate GABA concentration Pearson’s r = 0.14, p = 
0.38. Daily use of ethanol, coded ordinally (Table 1), was not correlated with right dentate 
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GABA concentration in ET cases (Spearman’s r = 0.07, p = 0.66) or left dentate GABA 
concentration in ET cases (Spearman’s r = −0.17, p = 0.28).
Finally, no correlation was found between tremor asymmetry and GABA asymmetry in ET 
cases (r = 0.15, p = 0.34).
Discussion
In this cross-sectional study, we used in-vivo magnetic resonance spectroscopy (MRS) to 
quantify GABA concentrations in two cerebellar volumes of interest, left and right, which 
included the dentate nucleus, comparing ET cases to age-matched controls. To our 
knowledge, there are no prior studies of dentate GABA concentration in ET cases and 
controls. We did not find a case-control difference. In ET but not controls, there was a 
difference in mean right vs. left dentate nucleus concentration.
The research tested the hypothesis that low dentate GABA concentration in ET cases would 
be a marker for PC loss in ET. One interpretation of the null finding (i.e., absence of a case-
control difference) is that it does not support the existence of PC loss in ET; however, there 
are other possibilities. A second interpretation, albeit speculative, is that the lack of an 
observed case-control difference in dentate GABA concentration could be due to the 
compensatory effects of terminal sprouting. Indeed, it is well established in animal models 
with PC loss, that when PCs are injured and/or transected, functional plasticity of the 
remaining PC synapses in deep nuclei results in a compensatory sprouting of their terminal 
boutons (35, 36). Indeed, PCs are endowed with considerable capability for terminal arbor 
growth and remodeling, in which injured PCs may develop a new terminal GABA-ergic 
arbor (35, 36). Studies of ET patients have indeed shown considerable remodeling of injured 
PC axons in the cerebellar cortex, although similar studies in the dentate nuclei have not 
been undertaken (37). In weaver mice, in which there is a considerable degeneration of PCs 
with resultant ataxia and tremor, and terminal sprouting is extensive, GABA-ergic 
innervation in mutants (i.e., mean density of GABA positive terminals in deep nuclei) is 
identical to or even greater than that of wild type mice. In other words, collateral sprouting 
from surviving PCs makes up for (or even over-compensates for) the loss of GABA-ergic 
terminals from PC degeneration (36). Our second observation, that the normal situation (i.e., 
the equivalence of right and left dentate GABA concentrations seen in our controls) is 
altered in ET, suggests that the PC-dentate-GABA system is disturbed in ET. The observed 
side-side difference in dentate GABA in ET could be the result of side-side differences in 
regenerative biology in ET. In other words, greater collateral sprouting in the right than left 
dentate nucleus in ET could lead both to a higher dentate GABA concentration on the right 
(2.01 ± 0.45) than left (1.68 ± 0.49) in ET and to an equivalence (or even slightly higher) 
right dentate concentration in ET cases (2.01 ± 0.45) than controls (1.86 ± 0.53) (Table 1). 
This interpretation of our data is speculative at the moment. Although postmortem studies in 
humans have demonstrated some changes in dentate GABA receptors (38), additional 
postmortem studies of PC sprouting in ET are needed.
A third interpretation of our data is that the readout we have chosen is not a good marker of 
PC loss. Indeed, there are several methodological as well as biological issues, which could 
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explain our null finding. First, MRS measures the overall concentration of GABA and does 
not provide information about the concentrations of GABA within different compartments 
(intracellular or extracellular at the synaptic or extrasynaptic levels) (39). The GABA 
concentration we were primarily interested in was PC synaptic GABA. There is some 
evidence to suggest that MRS-GABA concentrations may better reflect the extrasynaptic 
GABA tone (39–41). Second, our VOI was large compared to the size of the dentate 
nucleus. The large VOI size was necessary in order to obtain a GABA-edited spectrum with 
sufficient signal to noise ratio for adequate quantification. Thus, it is conceivable that our 
sensitivity to detect very small changes in dentate GABA may have been insufficient, 
especially if the GABA concentration of the surrounding cerebellar tissue, which was co-
measured, did not change. Third, the biological signal we are attempting to measure could 
be more subtle than we had hypothesized and the technology may not allow us to detect such 
a signal. Fourth, while the major postmortem brain changes observed in ET are in the 
cerebellum, in 10–15% of ET cases, there are brainstem Lewy bodies with less involvement 
of the cerebellum (6). The clinical features that differentiate these two groupings of ET cases 
are not clear. Inclusion of both groupings would have lowered our study power. Fifth, in 
addition to the GABA present in PC nerve terminals in the dentate nucleus, the deep 
cerebellar nuclei, at least in mice, contain intrinsic neuronal populations that also express 
GABA (42). The presence of such GABA-ergic neurons could have made it more difficult 
for us to detect changes specific to the PC-associated GABA pool across our study groups. 
Finally, we measured static GABA concentrations rather than dynamic concentrations (i.e., 
change over time), and future studies would benefit from a longitudinal approach to this 
question.
While it is conceivable that a larger dentate volume in ET cases could have masked a 
reduction in GABA concentration in our ET cases, we do not think this was the case. First, 
there is no conceivable biological reason why dentate volume would be larger in ET cases 
than similarly aged controls. Second, our estimate of right and left dentate volumes was 
similar in ET cases and controls (Table 1).
In summary, we did not detect a reduction in dentate GABA concentration in ET cases vs. 
controls. One interpretation of the finding is that it does not support the existence of PC loss 
in ET; however, an alternative interpretation is the observed pattern could be due to the 
effects of terminal sprouting in ET (i.e., collateral sprouting from surviving PCs making up 
for the loss of GABA-ergic terminals from PC degeneration).
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Figure 1. 
Left: Representative GABA-edited spectrum from the dentate VOI showing the raw data 
(black) and the LCModel fit (red). Right: Placement of the GABA VOI, containing the left 
cerebellar dentate.
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Figure 2A. 
Dentate GABA concentration in ET cases, comparing right to left side
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Figure 2B. 
Dentate GABA concentration in controls, comparing right to left side
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Figure 3. 
Dentate GABA asymmetry in controls (left) and ET cases (right)
The mean value of GABA asymmetry (right dentate GABA concentration minus left dentate 
GABA concentration) was 0.34 ± 0.62 in ET cases (values on right) and 0.07 ± 0.62 in 
controls (values on left) (for case-control comparison, p = 0.05). The horizontal line at zero 
indicates a point in which the GABA concentration in the left and right dentate are equal. 
Values above the line indicate that the right dentate GABA concentration is greater than the 
left; values below the line indicate that the left dentate GABA concentration is greater than 
the right.
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Table 1
Demographic and Clinical Comparison of ET Cases and Controls
Variable ET Cases Controls Significance
N 45 35
Age in years 74.98 ± 6.16 73.26 ± 6.06 0.22a
Male gender 26 (57.8) 10 (28.6) 0.009b
Right handed 38 (84.4) 31 (88.6) 0.85c
White race 43 (95.6) 32 (91.4) 0.65c
Married 28 (62.2) 22 (62.9) 0.95b
Education (years) 17.9 ± 3.7 [18.0] 18.2 ± 4.8 [17.5] 0.87d
Current smoker 1 (2.2) 1 (2.9) 1.00c
MoCA score 27.5 ± 2.3 [28.0] 28.2 ± 1.7 [28.0] 0.22d
Number of prescription medications 3.5 ± 2.5 [3.0] 3.2 ± 2.9 [3.0] 0.40d
Ethanol use
 <1 drink/week
 <1 drink/day
 1 drink/day
 > 1 drink/day
21 (46.7)
14 (31.1)
3 (6.7)
7 (15.6)
20 (57.1)
6 (17.1)
5 (14.3)
4 (11.4)
0.34b
Total tremor score 21.5 ± 4.1 [22.0] 5.6 ± 2.3 [5.0] <0.001d
Neck or jaw tremor 26 (57.8) NA NA
Age of tremor onset in years 41.5 ± 20.4 [47.5] NA NA
Tremor duration in years 34.0 ± 19.6 [30.0] NA NA
Prescribed medication for tremor at some point 29 (64.4) NA NA
Left dentate volume (c.c.) 1.37 ± 0.22 1.40 ± 0.21 0.42a
Right dentate volume (c.c.) 1.47 ± 0.24 1.49 ± 0.21 0.69a
Left dentate GABA concentration (i.u.) 1.68 ± 0.49 1.80 ± 0.53 0.69a
Right dentate GABA concentration (i.u.) 2.01 ± 0.45 1.86 ± 0.53 0.53a
All values represent mean ± standard deviation or number (percentage).
c.c. = cubic centimeters, i.u. = institutional units, MoCA = Montreal Cognitive Assessment.
aStudent’s t test
bChi-square test
c
Fisher’s exact test
d
Mann-Whitney test
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